RELIEF THERAPEUTICS Holding SA Stock CINNOBER BOAT
Equities
0QKQ
CH0100191136
Biotechnology & Medical Research
Sales 2022 | 6.08M 6.74M 9.18M | Sales 2023 | 6.03M 6.68M 9.1M | Capitalization | 24.96M 27.64M 37.66M |
---|---|---|---|---|---|
Net income 2022 | -50M -55.38M -75.46M | Net income 2023 | -98M -109M -148M | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 14.89M 16.5M 22.48M | Net cash position 2023 | 10.25M 11.36M 15.47M | EV / Sales 2023 | 2.44 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | 55 | 22-01-27 |
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 21-05-26 |
Michelle Lock
CEO | Chief Executive Officer | 55 | 22-01-27 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |